FI954386L - (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö - Google Patents

(1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö Download PDF

Info

Publication number
FI954386L
FI954386L FI954386A FI954386A FI954386L FI 954386 L FI954386 L FI 954386L FI 954386 A FI954386 A FI 954386A FI 954386 A FI954386 A FI 954386A FI 954386 L FI954386 L FI 954386L
Authority
FI
Finland
Prior art keywords
triazolo
preparation
quinoxaline derivatives
quinoxaline
derivatives
Prior art date
Application number
FI954386A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954386A7 (fi
FI954386A0 (fi
Inventor
Poul Jacobsen
Flemming Elmelund Nielsen
Lone Jeppesen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI954386A7 publication Critical patent/FI954386A7/fi
Publication of FI954386A0 publication Critical patent/FI954386A0/fi
Publication of FI954386L publication Critical patent/FI954386L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI954386A 1993-03-19 1994-02-25 (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö FI954386L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93310A DK31093D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-03-19 1993-03-19
PCT/DK1994/000077 WO1994021639A1 (en) 1993-03-19 1994-02-25 [1,2,4] TRIAZOLO [4,3-a] QUINOXALINE DERIVATIVES, THEIR PREPARATION AND USE

Publications (3)

Publication Number Publication Date
FI954386A7 FI954386A7 (fi) 1995-09-18
FI954386A0 FI954386A0 (fi) 1995-09-18
FI954386L true FI954386L (fi) 1995-09-18

Family

ID=8092112

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954386A FI954386L (fi) 1993-03-19 1994-02-25 (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö

Country Status (16)

Country Link
US (1) US5559106A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0691969A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH08507536A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100313051B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1041930C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU685783B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2158545A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK31093D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI954386L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT73419A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL108800A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO305286B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ262365A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW304195B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994021639A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA941926B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4314592A1 (de) * 1993-04-28 1994-11-03 Schering Ag Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE69511420T2 (de) * 1994-09-16 2000-03-30 Novo Nordisk A/S, Bagsvaerd [1,2,4]-TRIAZOLO[4,3-a]CHINOXALINON-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG
AU706737B2 (en) * 1994-09-16 1999-06-24 Novo Nordisk A/S {1,2,4}triazolo{4,3-a}quinoxalinone derivatives, their preparation and use
US5679680A (en) * 1995-02-16 1997-10-21 Warner-Lambert Company α-substituted hydrazides having calpain inhibitory activity
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
CA2310072A1 (en) 1997-11-11 1999-05-20 Hiroyuki Ohno Fused pyrazine compounds
WO1999040063A1 (fr) * 1998-02-06 1999-08-12 Yoshitomi Pharmaceutical Industries, Ltd. Nouveaux derives de l'acide hydroxamique de type azapeptide
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
US8299080B2 (en) * 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
JP5609861B2 (ja) 2009-03-05 2014-10-22 アステラス製薬株式会社 キノキサリン化合物
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer
AU2011299936A1 (en) 2010-09-07 2013-03-28 Astellas Pharma Inc. Quinoxaline compound
BR112013033375B1 (pt) 2011-06-27 2022-05-10 Janssen Pharmaceutica N.V Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxa-lina, seu uso, composição farmacêutica que os compreende, processo de preparação dos mesmos, solução estéril e composto intermediário
RU2657540C2 (ru) 2012-06-26 2018-06-14 Янссен Фармацевтика Нв Комбинации, содержащие ингибиторы pde 2, такие как 1-арил-4-метил-[1,2,4]триазоло[4,3-а]хиноксалиновые соединения, и ингибиторы pde 10, для применения в лечении неврологических или метаболических расстройств

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) * 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
US4547501A (en) * 1983-09-02 1985-10-15 Pfizer Inc. Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
AU3767793A (en) * 1992-04-03 1993-11-08 Yamanouchi Pharmaceutical Co., Ltd. Fused quinoxalinone derivative and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
AU685783B2 (en) 1998-01-29
CN1122601A (zh) 1996-05-15
NZ262365A (en) 1997-05-26
KR100313051B1 (ko) 2002-02-28
FI954386A7 (fi) 1995-09-18
WO1994021639A1 (en) 1994-09-29
CN1041930C (zh) 1999-02-03
HUT73419A (en) 1996-07-29
IL108800A (en) 1998-02-22
AU6201894A (en) 1994-10-11
KR960701057A (ko) 1996-02-24
DK31093D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-03-19
ZA941926B (en) 1995-09-18
HU9502726D0 (en) 1995-11-28
US5559106A (en) 1996-09-24
FI954386A0 (fi) 1995-09-18
TW304195B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-05-01
NO953673D0 (no) 1995-09-18
CA2158545A1 (en) 1994-09-29
NO305286B1 (no) 1999-05-03
IL108800A0 (en) 1994-06-24
EP0691969A1 (en) 1996-01-17
JPH08507536A (ja) 1996-08-13
NO953673L (no) 1995-11-17

Similar Documents

Publication Publication Date Title
FI971225L (fi) Pyrrolo(2,3-d)pyrimidiinit ja niiden käyttö
IL111526A0 (en) 7H-imidazo (1,2-a) pyrazin-8-one derivatives and their preparation and use
FI952179A7 (fi) Uusia 3,3-difenyylipropyyliamiineja, niiden käyttö ja valmistus
FI945281A7 (fi) Heterosykliset yhdisteet, niiden valmistus ja käyttö
FI940904A7 (fi) Oksatsolidiinidionijohdannaiset, niiden valmistus ja käyttö
FI990387A7 (fi) Tienopyrimidiinijohdannaiset, niiden valmistus ja käytt"
FI954386A0 (fi) (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö
FI940696A7 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
FI955304L (fi) (1,2,4)triatsoli(4,3-a)kinoksaliiniyhdisteitä, niiden valmistus ja käyttö
DE69633503D1 (de) 1,2,4- triazolo (4,3-b) pyridazinderivate und ihre verwendung
FI20030361L (fi) Perhydro-1H-pyrido[1,2-a]pyratsiinijohdannaiset
AU646582B2 (en) Imidazo (2,1-b) benzothiazole-3-acetamide derivatives, their preparation and their use in therapeutics
FI954229L (fi) Heterosykliset yhdisteet, niiden käyttö ja valmistus
FI930716A7 (fi) Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö
FI940186A7 (fi) 9H-imidatso/1,2-a/bentsimidatsoli-3-asetamidijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
FI923458A7 (fi) 4,5-sykloalkano-3-bentsatsepin-7-olijohdannaiset ja niiden käyttö
FI971075L (fi) (1,2,4)triatsolo(4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö
EP0511152A3 (en) Quinoxaline compounds, their preparation and use
FI971076A7 (fi) (1,2,4)triatsolo (4,3-a)kinoksalinonijohdannaiset, niiden valmistus ja käyttö
AU1850092A (en) 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
FI955141L (fi) Pyrido(1,2,3-de)kinoksaliinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeissä
ZA939760B (en) 2-Thienylimidazo(2,1-b)benzothiazole-3-acetic acid derivatives their preparation and their use
AU2141595A (en) 1,2,4-triazolo{4,3-a}pyrazine-4-one derivatives, preparation thereof and drugs containing same
ZA943114B (en) [1,2,4]Triazolo[4,3-a]quinoxaline compounds their preparation and use
ZA94291B (en) 9H-Imidazo(1,2-a)Benzimidazole-3-acetamide derivatives their preparation and their therapeutic application